A Study on Antibiotic Resistance in Patients with Nosocomial Infections and its Risk Factors
| Vol-4 | Issue-04 | April 2019 | Published Online: 15 April 2019 PDF ( 720 KB ) | ||
| Author(s) | ||
| Anisha Sarkar 1; Dr. Neelam Tripathi 2 | ||
|
1Research Scholar, Department of Microbiology, Sri Satya Sai University of Technology & Medical Sciences, Sehore , MP 2Research Guide, Sri Satya Sai University of Technology & Medical Sciences, Sehore , MP |
||
| Abstract | ||
Introduction:Pseudomonas aeruginosa (P. aeruginosa) is impervious to different anti-toxins and can cause genuine nosocomial diseases with high grimness and mortality. In this clinical examination, we explored the hazard factors in patients who were determined to have P. aeruginosa-related nosocomial disease. Methods:A review case control study incorporating patients with P. aeruginosa-related nosocomial disease. Patients who were impervious to any of the six anti-toxins (imipenem, meropenem, piperacillin-tazobactam, ciprofloxacin, amikacin, and ceftazidime) comprised the investigation gathering. Results:One hundred and twenty disengages were disconnected. Different hazard factors were identified for every anti-infection in the univariate examination. In the multivariate investigation, past cefazolin utilize was found as an autonomous hazard factor for the advancement of imipenem opposition (OR = 3.33; CI 95% [1.11–10.0]; p = 0.03), while past cerebrovascular assault (OR = 3.57; CI 95% [1.31–9.76]; p = 0.01) and past meropenem use (OR = 4.13; CI 95% [1.21–14.07]; p = 0.02) were free factors for the improvement of meropenem obstruction. For the improvement of protection from ciprofloxacin, hospitalization in the nervous system science emergency unit (= 4.24; CI 95% [1.5–11.98]; p = 0.006) and mechanical ventilator application (OR = 11.7; CI 95% [2.24–61.45]; p = 0.004) were free hazard factors. Conclusion:The fastidious use of contact measures can diminish the pace of nosocomial diseases. |
||
| Keywords | ||
| Nosocomial Infection, Antibiotic Resistance, Pseudomonas aeruginosa | ||
|
Statistics
Article View: 340
|
||

